---
document_datetime: 2023-09-21 20:55:15
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rasilez-epar-all-authorised-presentations_en.pdf
document_name: rasilez-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.3246474
conversion_datetime: 2025-12-22 13:20:02.901055
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                                       |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------------------------------------------|
| EU/1/07/405/021  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 14 tablets                                      |
| EU/1/07/405/022  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 28 tablets                                      |
| EU/1/07/405/023  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 30 tablets                                      |
| EU/1/07/405/024  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 50 tablets                                      |
| EU/1/07/405/025  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 56 tablets                                      |
| EU/1/07/405/026  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 56 x 1 tablets (unit dose)                      |
| EU/1/07/405/027  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 90 tablets                                      |
| EU/1/07/405/028  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 98 tablets                                      |
| EU/1/07/405/029  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 98 (2 x 49 x 1) tablets (unit dose) (multipack) |
| EU/1/07/405/030  | Rasilez           | 150 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 280 (20 x 14) tablets (multipack)               |
| EU/1/07/405/031  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 14 tablets                                      |
| EU/1/07/405/032  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 28 tablets                                      |
| EU/1/07/405/033  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 30 tablets                                      |
| EU/1/07/405/034  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 50 tablets                                      |
| EU/1/07/405/035  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 56 tablets                                      |
| EU/1/07/405/036  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 56 x 1 tablets (unit dose)                      |
| EU/1/07/405/037  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 90 tablets                                      |
| EU/1/07/405/038  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 98 tablets                                      |
| EU/1/07/405/039  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 98 (2 x 49 x 1) tablets (unit dose) (multipack) |
| EU/1/07/405/040  | Rasilez           | 300 mg     | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC)   | 280 (20 x 14) tablets (multipack)               |